Evidence map›Paper›PMID 37246613›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2023

Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.

Kathleen M Buchheit, Jonathan Hacker, Rie Maurer, Alanna McGill, Tessa Ryan, Jillian C Bensko, Tanya M Laidlaw

Open access · bronzeAbstract readLetter
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Efficacy of Biologics in NSAID-ERD: United Airways From the Nose to the Bronchi.The journal of allergy and clinical immunology. In practice · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kathleen M BuchheitDivision of Allergy and Clinical Immunology, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Jonathan HackerDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Rie MaurerCenter for Clinical Investigation, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alanna McGillDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Tessa RyanDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0009-0001-7568-4721
Jillian C BenskoDivision of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Tanya M LaidlawDivision of Allergy and Clinical Immunology, Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.ORCID 0000-0001-6709-9795
Brigham and Women's Hospital · US

Funding

Therapeutic Control of Aspirin-Exacerbated Respiratory DiseaseU19AI095219 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Maria Gutierrez-Arcelus · 2011 to 2026
$29.1M
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
Prostaglandin D2: A Key Mediator of Aspirin-Exacerbated Respiratory DiseaseR01HL128241 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LAIDLAW, TANYA MARIA · 2015 to 2019
$2.2M
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory DiseaseK23AI139352 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI BUCHHEIT, KATHLEEN MARY · 2019 to 2023
$1.0M
NHLBI NIH HHS R01 HL128241NIAID NIH HHS K23 AI139352NIAID NIH HHS T32 AI007306NIAID NIH HHS U19 AI095219
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Asthma, Aspirin-InducedNasal PolypsRespiratory Tract DiseasesRhinitisAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agents, Non-SteroidalAspirinChronic DiseaseDesensitization, ImmunologicHumansAntibodies, Monoclonal, HumanizedAnti-Inflammatory Agents, Non-SteroidalAspirindupilumabaspirin desensitizationaspirin-exacerbated respiratory diseaseaspirin therapy after desensitizationasthmachronic rhinosinusitisdupilumabnasal polypsNSAID-exacerbated respiratory disease

Identifiers

PMID37246613
PMCPMC10524624
OpenAlexW4378640259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.